Biomarkers

Results from the first cohort of the AURORAX 087A study show the new biomarker-based test provides a more robust basis for making decisions on treatment than scans alone

The test could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas

Nanopore-based sensors could transform diagnostics

New study offers hope that a simple test can be developed to identify preeclampsia earlier in pregnancy

Recent findings from scientists at St. Jude Children’s Research Hospital are showing promise for assessing cardiomyopathy risk in childhood cancer survivors

Better diagnostics for neurodegenerative diseases can improve clinical trials to help move groundbreaking therapies to approval

AI-identified biomarker-based test reduces need for prostate biopsies in men with high PSA levels

Analyzing RNA in urine for cell changes may allow some individuals to avoid invasive biopsies

Steps that buttress biomarker analysis include laboratories adopting platform-agnostic technologies

The blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer